ArticleJournal of orthopaedic case reports2026
Giant Cell Tumor of the Distal Phalanx of the Great Toe: Case Report.
Article in Journal of orthopaedic case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Giant cell tumor (GCT) of bone is a benign but locally aggressive neoplasm that most commonly involves the epiphyseal-metaphyseal regions of long bones. Involvement of the foot is rare, and occurrence in the distal phalanx of the great toe is exceptionally uncommon. GCTs arising in small bones are known to exhibit more aggressive behavior and higher recurrence rates than those in long bones, posing challenges for management. Case Report: We report the case of a young adult presenting with progressive pain and swelling of the great toe. Radiographs and magnetic resonance imaging demonstrated an expansile osteolytic lesion of the distal phalanx with cortical destruction and soft-tissue extension. Histopathological examination following open biopsy confirmed the diagnosis of GCT of bone. The patient received three doses of denosumab, followed by surgical resection of the distal phalanx with the intent of limb preservation. The post-operative course was uneventful. At the 1-year follow-up, the patient remains symptom-free, with no evidence of recurrence. Conclusion: GCT of the distal phalanx of the great toe is a rare entity with aggressive local behavior. Early diagnosis, histopathological confirmation, and appropriate surgical planning are essential for achieving local control. Limb-preserving strategies can be considered in selected cases, but vigilant follow-up is mandatory due to the high risk of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.